Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9474 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.9221 |
High Similarity |
NPD2801 |
Approved |
0.9156 |
High Similarity |
NPD1934 |
Approved |
0.9007 |
High Similarity |
NPD1511 |
Approved |
0.8889 |
High Similarity |
NPD1512 |
Approved |
0.8827 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8827 |
High Similarity |
NPD6166 |
Phase 2 |
0.8827 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8824 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8782 |
High Similarity |
NPD4380 |
Phase 2 |
0.878 |
High Similarity |
NPD7054 |
Approved |
0.8727 |
High Similarity |
NPD7074 |
Phase 3 |
0.8727 |
High Similarity |
NPD7472 |
Approved |
0.8696 |
High Similarity |
NPD5494 |
Approved |
0.8625 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8625 |
High Similarity |
NPD3882 |
Suspended |
0.8623 |
High Similarity |
NPD7251 |
Discontinued |
0.8606 |
High Similarity |
NPD3818 |
Discontinued |
0.8571 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8571 |
High Similarity |
NPD7075 |
Discontinued |
0.8563 |
High Similarity |
NPD6797 |
Phase 2 |
0.8562 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8562 |
High Similarity |
NPD3817 |
Phase 2 |
0.85 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8487 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8487 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8462 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8462 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8457 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8443 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8431 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8421 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8415 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8385 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8355 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8333 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8333 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8323 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8261 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8214 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8144 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8129 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8092 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8084 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8065 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8061 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.805 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8012 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7987 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7977 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7974 |
Intermediate Similarity |
NPD943 |
Approved |
0.7962 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7941 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7939 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7911 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7888 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7888 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7888 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7888 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7866 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7865 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7862 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7857 |
Intermediate Similarity |
NPD919 |
Approved |
0.7857 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7857 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7806 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7799 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7763 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7756 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7727 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7712 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7688 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7683 |
Intermediate Similarity |
NPD920 |
Approved |
0.768 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7662 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7627 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.761 |
Intermediate Similarity |
NPD6100 |
Approved |
0.761 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.761 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7607 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.76 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7588 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7572 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7561 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7546 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7544 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7531 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.753 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7514 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7514 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7487 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD3226 |
Approved |
0.747 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7456 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7455 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7443 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7443 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7438 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7423 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7423 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7414 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7389 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7389 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7378 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7372 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7358 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7358 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7358 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7356 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7353 |
Intermediate Similarity |
NPD37 |
Approved |
0.7346 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7346 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7344 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7329 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7326 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7326 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7326 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7314 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7314 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7302 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7302 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7302 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7302 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7302 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7302 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7302 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7294 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7289 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7277 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7268 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7268 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7268 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7261 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7255 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7216 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7197 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7197 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7194 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7194 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7188 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7188 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7181 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7181 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7176 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7176 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7169 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7161 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.715 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.715 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7135 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7135 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7128 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7125 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7115 |
Intermediate Similarity |
NPD3225 |
Approved |
0.711 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7107 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7097 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.707 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7069 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7063 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7056 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7056 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7048 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7037 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7037 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7032 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.703 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.702 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7016 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7016 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7012 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7006 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.6995 |
Remote Similarity |
NPD7240 |
Approved |
0.6988 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6987 |
Remote Similarity |
NPD9717 |
Approved |
0.6987 |
Remote Similarity |
NPD1608 |
Approved |
0.6983 |
Remote Similarity |
NPD5242 |
Approved |
0.6978 |
Remote Similarity |
NPD1729 |
Discontinued |
0.6975
|
Remote Similarity |
NPD4060 |
Phase 1 |